Similar Papers

Paper Title
Journal
Date
Author
Suppression of tumor growth by in vivo administration of a recombinant human-mouse chimeric monoclonal antibody.
Y Nishimura ... T Watanabe
Japanese Journal of Cancer Research GANN | VOL. 78
Y Nishimura, et. al.Y Nishimura ... T Watanabe
01 Jan 1987
Efficacy and Safety of Recombinant Human-Mouse Chimeric Anti-CD20 Monoclonal Antibody (SCT400) Combined with CHOP in Patients with Treatment-Naïve Diffuse Large B-Cell Lymphoma: A Multicenter, Randomized, Single-Blind, Parallel Active-Controlled, Phase III Study
Yuankai Shi ...
Blood | VOL. 138
Yuankai Shi, et. al.Yuankai Shi ...
05 Nov 2021
Clinical trials of a mouse-human chimeric anti-CD20 monoclonal antibody (rituximab) for B cell non-Hodgkin's lymphoma in Japan.
Kensei Tobinai
Cancer chemotherapy and pharmacology | VOL. Suppl 48 1
Kensei TobinaiKensei Tobinai
01 Jul 2001
Tolerance and pharmacodynamics phase Ⅰ clinical trial study of chimeric anti-CD20 monoclonal antibody IBI301 in Chinese patients with CD20-positive non-Hodgkin's lymphoma
...
Chinese Journal of Hematology | VOL. 39
, et. al. ...
01 Apr 2018
View more papers

More From: Journal of Cancer

Paper Title
Journal
Date
Author
Intercellular Adhesion Molecule 3: Structure, Cellular Functions, and Emerging Role in Human Diseases
Xinzhuang Shen ... Wenzhi Shen
Journal of Cancer | VOL. -
Xinzhuang Shen, et. al.Xinzhuang Shen ... Wenzhi Shen
27 Jan 2025
The Role of MATN3 in Cancer Prognosis and Immune Infiltration Across Multiple Tumor Types
Chongjiu Qin ... Guangzhi Zhu
Journal of Cancer | VOL. -
Chongjiu Qin, et. al.Chongjiu Qin ... Guangzhi Zhu
27 Jan 2025
Integrative multi-omics and machine learning identify a robust signature for discriminating prognosis and therapeutic targets in bladder cancer
Zhiyong Tan ... Haifeng Wang
Journal of Cancer | VOL. -
Zhiyong Tan, et. al.Zhiyong Tan ... Haifeng Wang
27 Jan 2025
LncRNA C2orf27A Promotes Gastric Cancer by Sponging MiR-610 and Elevating NOX4 Expression
Mingkai Zhuang ... Fenglin Chen
Journal of Cancer | VOL. -
Mingkai Zhuang, et. al.Mingkai Zhuang ... Fenglin Chen
27 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.